Autonomic Pharmacology Flashcards
Preganglionic neuron receptors and neurotransmitters
Nicotinic cholinergic receptor for both parasympathetic and sympathetic nervous system, both NT’s acetylcholine
Postganglionic neuron receptors and neurotransmitters
Sympathetic nervous system: NoEpi, Epi, and Dopamine on Adrenergic receptor (Alpha, Beta, or Dopamine receptors)
Parasympathetic nervous system: Acetylcholine and muscarinic cholinergic receptor
Synthesis of catecholamine’s
Phenylalanine -> Tyrosine (Tyrosine Hydroxylase rate limiting enzyme, inhibited by increased NE synthesis) -> DOPA -> Dopamine -> Norepinephrine -> Epinephrine (primarily synthesized in adrenal medulla)
Metabolism of catecholamine’s
COMT (cathechol-O-methyl transferase): Metabolizes catecholamine in the synapse (~20%)
MAO (monoamine oxidase): Metabolizes catecholamine when it is reuptaked into the neuron if it isn’t in a vesicle
Presynaptic Receptor
“Auto receptor”
Inhibitory effect/negative feedback, when stimulated decreases NT release from the synapse
Alpha agonist affect on eye, HR, blood vessels, GI tract, uterus, liver
Eye: Mydriasis (pupil dilation) HR: Bradycardia (reflex) Blood vessels: Vasoconstriction GI tract: Decreased motility and secretion Uterus: Contraction Liver: Increased blood sugar
Alpha blocker affect on eye, HR/contractility, blood vessels
Eye: Slight Miosis (pupil constriction)
HR: Tachycardia (reflex), slight reflex increase in contractility
Blood vessels: Vasodilation
Beta agonist affect on HR/contractility/conduction velocity, blood vessels, lungs, GI tract, uterus, liver
Heart: Tachycardia, increased contractility, increased conduction velocity
Blood vessels: Vasodilation
Lungs: Bronchodilation
GI Tract: Decreased motility and secretion
Uterus: Relax
Liver: Increased blood sugar
Beta blocker affect on eye, HR/contractility/conduction velocity, blood vessels, lungs, liver
Eye: Decreased intra-ocular pressure Heart: Bradycardia, decreased contractility, decreased conduction velocity Blood vessels: Vasoconstriction Lungs: Bronchoconstriction Liver: Hypoglycemia
Cholinergic agonist affect on eye, heart, lungs, GI tract
Eye: Miosis (pupil constriction), decreased intraocular pressure
HR: Bradycardia, slightly decreased contractility, decreased conduction velocity
Lungs: Bronchoconstriction
GI Tract: Increased motility and secretion
Anticholinergic affect on eye, heart, lungs, GI tract
Eye: Mydriasis (dilation), cycloplegia (loss of accommodation for distance), increased intraocular pressure
Heart: Tachycardia, slightly increased contractility, increased conduction velocity
Lungs: Slight bronchodilation
GI Tract: Decreased motility and secretion
Phenylephrine (receptor, effect on SBP, DBP, HR, SVR)
Pure alpha agonist SBP: +++ DBP: +++ HR - SVR: +++
Norepinephrine (receptor, effect on SBP, DBP, HR, SVR)
Alpha agonist, some beta SBP: +++ DBP: ++ HR: + SVR: +++
Epinephrine (receptor, effect on SBP, DBP, HR, SVR)
Beta agonist, some alpha SBP: ++ DBP: -- HR: +++ SVR: -
DoButamine (receptor, effect on SBP, DBP, HR, SVR)
Pure beta agonist SBP: ++ DBP: --- HR: +++ SVR: ---